Get startedLog in
    Picture of Kindstar Globalgene Technology logo

    9960 — Kindstar Globalgene Technology Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareBalancedSmall CapValue Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Kindstar Globalgene Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue9311,387967928934
    Cost of Revenue
    Gross Profit484599450436411
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses2,3831,301916973959
    Operating Profit-1,45285.851.4-45.1-25.5
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes-1,45483.343.3-56.2-40.4
    Provision for Income Taxes
    Net Income After Taxes-1,45477.536.4-60.7-55.1
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-1,45475.541.3-54.6-58.7
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-1,45475.541.3-54.6-58.7
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-2.940.0960.02-0.062-0.059
    Dividends per Share